CLOSE X

Achintya Commodities Pvt Ltd

Search
Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE5857.00-49.95 (-0.85 %)
PREV CLOSE ( ) 5906.95
OPEN PRICE ( ) 5825.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 17791
TODAY'S LOW / HIGH ( )5648.00 5870.55
52 WK LOW / HIGH ( )4941.7 7077.7
NSE5856.50-50 (-0.85 %)
PREV CLOSE( ) 5906.50
OPEN PRICE ( ) 5851.00
BID PRICE (QTY) 5856.50 (135)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 513534
TODAY'S LOW / HIGH( ) 5647.50 5869.50
52 WK LOW / HIGH ( )4955 7071.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 66966300 / 400

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
31Mar Divi’s Laboratories informs about clos
Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Repor..
30Jan Divis Laboratories informs about board
Divis Laboratories has informed that the meeting of the Board of Directo..
03Jan Divi's Laboratories informs about cert
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
31Dec Divi’s Laboratories informs about clos
Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Repor..
10Nov Divi's Laboratories reports 35% rise i
Divi's Laboratories has reported result for second quarter ended Septemb..
MORE
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit598022090
Gross Profit 7980 29290
Operating Profit 994033310
Net Sales 2578091980
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
up  2146.70 (3.09%)
M.Cap ( in Cr)1326.24
Hester Biosciences (BSE)
up  1427.90 (4.01%)
M.Cap ( in Cr)1214.70
Haleos Labs (BSE)
up  1299.00 (3.61%)
M.Cap ( in Cr)392.72
RPG Life Sciences (BSE)
up  1922.95 (2.35%)
M.Cap ( in Cr)3180.37
Albert David (BSE)
up  653.15 (6.34%)
M.Cap ( in Cr)372.76
MORE
Shareholding Pattern
PROMOTERS 51.88%
MUTUAL FUNDS/UTI 13.73%
NON-INSTITUTION 8.76%
FI/BANKS/INSURANCE 4.96%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
ICICI Pru Nifty Pharma Index Fund-Reg(G)10.94
Nippon India Nifty Pharma ETF10.92
HDFC Pharma and Healthcare Fund-Reg(G)10.06
Quant Healthcare Fund-Reg(G)9.99
ITI Pharma & Healthcare Fund-Reg(G)9.03
Aditya Birla SL Nifty Healthcare ETF8.96
ICICI Pru Nifty Healthcare ETF8.96
MORE
ATTENTION INVESTORS KYC IPOUPDATES

Corporate office

Achintya Tower,
7/118 E,
Swaroop Nagar,
Kanpur - 208002

Registered office

12th Floor, Unit No 1208,
Dalal Street Commercial
Co-Operative Society Ltd,
Block No - 53E, Gift City,
Zone - 5, Gandhi Nagar.
Gujarat, 382050

call us

0512-6670700

e-mail

info@achintya.co.in

Investor Grievance

ig@achintya.co.in

useful links

MEMBERSHIP NOS. :

Achintya Securities Limited.: SEBI Registration No. INZ000009837 | Member Code: NSE: 13302, BSE: 6468, MCX: 57305, MSEI-56100 | DP SEBI Registration No.IN-DP-596-2021 | NCDEX membership - 1317.

Achintya Commodities Pvt. Ltd.: SEBI Registration No. INZ000015535 | Member Code: NSE: 90438, BSE: 6943, MCX: 31640, NCDEX: 00335, MSEI-85400

Copyrights  ©  2020 Achintya All rights reserved.
Designed, Developed and Content provided by Accord Fintech Pvt Ltd.